Polyglutamine pathogenesis

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 354, Issue 1386, 1999, Pages 1005-1011

  Ross, Christopher A ^a   Wood, Jonathan D ^a   Schilling, Gabriele ^a   Peters, Matthew F ^a   Nucifora Jr , Frederick C ^a   Cooper, Jillian K ^a   Sharp, Alan H ^a   Margolis, Russell L ^a   Borchelt, David R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dentatorubral pallidoluysian atrophy; Huntington's disease; Neuronal toxicity; Transgenic mouse models

Indexed keywords

ANIMALIA; MUS MUSCULUS;

EID: 0033614776     PISSN: 09628436     EISSN: None     Source Type: Journal    
DOI: 10.1098/rstb.1999.0452     Document Type: Article

References (82)

1. Andrew, S. E. (and 11 others) 1993 The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nature Genet. 4, 398-403.
2. Andrew, S. E., Goldbery, Y., P. & Hayden, M. R. 1997 Rethinking genotype and phenotype correlations in polyglutamine expansion disorders. Hum. Mol. Genet. 6, 2005-2010.
3. Aronin, N. (and 16 others) 1995 CAG expansion affects the expression of mutant huntingtin in the Huntington's disease brain. Neuron 15, 1193-1201.
4. Becher, M.W., Kotzuk, J. A., Sharp, A. H., Davies, S.W., Bates, G. P., Price, D. L. & Ross, C. A. 1998 Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 triplet repeat length, Neurobiol. Dis. 4, 387-397.
5. Block-Galarza, J., Chase, K. O., Sapp, E., Vaughn, K. T., Vallee, R. B., DiFiglia, M. & Aronin, N. 1997 Fast transport and retrograde movement of huntingtin and HAP1 in axons. NeuroReport 8, 2247-2251.
6. Brooks, B. P. & Fischbeck, K. H. 1995 Spinal and bulbar muscular atrophy: a trinucleotide-repeat expansion nuerodegenerative disease. Trends Neurosci, 18, 459-461.
7. Brooks, B. P., Paulson, H. L., Merry, D. E., Salazar-Grueso, F., F., Brinkmann, A. O., Wilson, E. M. & Fischbeck, K. H. 1997 Characterization of an expanded glutamine repeat androgen receptor in a neuronal cell culture system. Neurobiol. Dis. 4, 313-323.
8. Burke, J. R., Enghild, J.J., Martin, M. E., Jou, Y.-S., Myers, R. M., Roses, A. D., Vance, J. M. & Strittmatter, W. J. 1996 Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Med. 2, 347-350.
9. Burright, E. N., Clark, H. B., Servadio, A., Matilla, T., Feddersen, R. M., Yunis, W. S., Duvick, L. A., Zoghbi, H. Y. & Orr, H. T. 1995 SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell 82, 937-948.
10. Burright, E. N., Davidson, J. D., Duvick, L. A., Koshy, B., Zoghbi, H. Y. & Orr, H. T. 1997 Identification of a self-association region within the SCA1 gene product, ataxin-1. Hum. Mol. Genet. 6, 513-518.
11. Cha, J.-H. J., Kosinski, C. M., Kerner, J. A., Alsdorf, S. A., Mangiarini, L., Davies, S. W., Penney, J. B., Bates, G. P. & Young, A. B. 1998 Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington's disease gene. Proc. Natl Acad. Sci. USA 95, 6480-6485.
12. Colomer, V., Engelender, S., Sharp, A. H., Duan, K., Cooper, J. K., Lanahan, A., Lyford, G., Worley, P. & Ross, C. A. 1997 Huntingtin-associated protein 1 (HAP1) binds to a tri-like polypeptide, with a rac1 guanine nucleotide exchange factor domain. Hum. Mol. Genet. 6, 1519-1525.
13. Cooper, J. K. (and 12 others) 1998 Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum. Mol. Genet. 7, 783-790.
14. Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L. & Bates, G. P. 1997 Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548.
15. De Rooij, K. E., Dorsman, J. C., Smoor, M. A., Den Dunnen, J. T. & Van Ommen, G. J. 1996 Subcellular localization of the Huntington's disease gene product in cell lines by immunofluorescence and biochemical subcellular fractionation. Hum. Mol. Genet. 5, 1093-1099.
16. DiFiglia, M. (and 11 others) 1995 Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14, 1075-1081.
17. DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Rates, G. P., Vonsattel, J. P. & Aronin, N. 1997 Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993.
18. Duyao, M. (and 41 others) 1993 Trinucleotide repeat length instability and age of onset in Huntington's disease. Nature Genet. 4, 387-392.
19. Engelender, S., Sharp, A. H., Colomer, V., Tokito, M. K., Lanahan, A., Worley, P., Holzbaur, E. L. F. & Ross, C. A. 1997 Huntingtin associated protein 1 (HAP1) interacts with-dynactin p150Glued and other cytoskeletal related proteins. Hum. Mol. Genet. 6, 2205-2212.
20. Faber, P. W., Barnes, G. T., Srinidhi, J., Chen, J., Gusella, J. F. & MacDonald, M. E. 1998 Huntingtin interacts with a family of WW proteins. Hum. Mol. Genet. 7, 1463-1474.
21. Faber, P. W., Alter, J. R., MacDonald, M. E. & Hart, C. 1999 Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron. Proc. Natl Acad. Sci. USA 96, 179-184.
22. Ferrante, R. J., Gutekunst, C.-A., Persichetti, F., McNeil, S. M., Kowall, N. W., Gusella, J. F., MacDonald, M. E., Beal, M. F. & Hersch, S. M. 1997 Heterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatum. J. Neurosci. 17, 3052-3063.
23. Goldberg, Y. P. (and 10 others) 1996 Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nature Genet. 13, 442-449.
24. Graveland, G. A., Williams, R. S. & DiFiglia, M. 1985 Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. Science 227, 770-773.
25. Gusella, J. F., Persichetti, F. & MacDonald, M. E. 1997 The genetic defect causing Huntington's disease: repeated in other contexts? Mol. Med. 3, 238-246.
26. Gutekunst, C. A., Li, S. H., Yi, H., Mulroy, J. S., Keummerle, S., Jones, R., Rye, D., Ierrante, R. J., Herch, S. M. & Li, X. J. 1999 Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J. Neurosci. 19, 2522-2534.
27. Hackam, A. S., Singaraja, R., Wellington, C. L., Metzler, M., McCutcheon, K., Zhang, T., Kalchman, M. & Hayden, M. R. 1998 The influence of huntingtin protein size on nuclear localization and cellular toxicity. J. Cell Biol. 141, 1097-1105.
28. Hackam, A. S., Singaraja, R., Zhang, T., Gan, L. & Hayden, M. R. 1999 In vitro evidence for both the nucleus and cytoplasmas subcellular sites of pathogencsis in Huntington's disease. Hum. Mol. Genet. 8, 25-33.
29. Holmberg, M. (and 10 others) 1998 Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum. Mol. Genet. 7, 913-918.
30. Hoogeveen, A. T., Willemsen, R., Meyer, N., De Rooij, K. E., Roos, R. A., Van Ommen, G. J. & Galjaard, H. 1993 Characterization and localization of the Huntington disease gene product. Hum. Mol. Genet. 2, 2069-2073.
31. Igarashi, S. (and 18 others) 1998 Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nature Genet. 18, 111-117.
32. Ikeda, H., Yamaguchi, M., Sugai, S., Aze, Y., Narumiya, S. & Kakizuka, A. 1996 Expanded polyglutamine in the Machado Joseph disease protein induces cell death in vitro and in vivo. Nature Genet. 13, 196-202.
33. Jackson, G. R., Salecker, I., Dong, X., Yao, X., Arnheim, N., Faber, P. W., MacDonald, M. E. & Zipursky, S. L. 1998 Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 21, 633-642.
34. Kalchman, M. A., Graham, R. K., Xia, G., Koide, H. B., Hodgson, J. G., Graham, K. C., Goldberg, Y. K., Gietz, R. D., Pickart, C. M. & Hayden, M. R. 1996 Huntingtin is ubiquitinated and interacts with a specific ubiquitin conjugated enzyme. J. Biol. Chem. 271, 19385-19394.
35. Kalchman, M. A. (and 13 others) 1997 HIP1, a human homologue of S. cerevisiae Sla2p, interacts with membane-associated huntingtin in the brain. Nature Genet. 16, 4453.
36. Klement, I. A., Skinner, P. J., Kaytor, M. D., Yi, H., Hersch, S. M., Clark, H. B., Zoghbi, H. Y. & Orr, H. T. 1998 Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95, 41-53.
37. Koshy, B., Matilla, T., Burright, E. N., Merry, D. E., Fischbeck, K. H., Orr, H. D. & Zoghbi, H. Y. 1996 Spino-cerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. Hum. Mol. Genet. 5, 1311-1318.
38. Lansbury Jr, P. T. 1997 Structural neurology: are seeds at the root of neuronal degenertion? Neuron 19, 1151-1154.
39. Li, M., Miwa, S., Kobayashi, Y., Merry, D. E., Yamamoto, M., Tanaka, F., Doyu, M., Hashizume, Y., Fischbeck, K. H. & Sobue, G. 1998 Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann. Neurol. 44, 249-254.
40. Li, S.-H. & Li, X.-J. 1998 Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats. Hum. Mol. Genet. 7, 777-782.
41. Li, S.-H., Hosseini, S. H., Gutekunst, C.-A., Hersch, S. M., Ferrante & Li, X.-J. 1998a A human HAP1 homologue. J. Biol. Chem. 273, 19220-19227.
42. Glued. J. Neurosci. 18, 1261-1269.
43. Li, X.-J., Li, S.-H., Sharp, A. H., Nucifora Jr, F. C., Schilling, G., Lanahan, A., Worley, P., Snyder, S. H. & Ross, C. A. 1995 A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378, 398-402.
44. Liu, Y. F. 1998 Expression of polyglutamine-expanded huntingtin activates the SEK1 JNK pathway and induces apoptosis in a hippocampal neuronal cell line. J. Biol. Chem. 273, 28873-28877.
45. Liu, Y. F., Deth, R. C. & Devys, D. 1997 SH3 domain-dependent association of huntingtin with epidermal growth factor receptor signaling complexes. J. Biol. Chem. 272, 8121-8124.
46. Lunkes, A. & Mandel, J.-L. 1998 A cellular model that recapitulates major pathogenic steps of Huntington's disease. Hum. Mol. Genet. 7, 1355-1361.
47. Mangiarini, L. (and 10 others) 1996 Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phonotype in transgenic mice. Cell 87, 493-506.
48. Martindale, D. (and 12 others) 1998 Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nature Genet. 18, 150-154.
49. Matilla, A., Koshy, B., Cummings, C. J., Isobe, T., Orr, H. T. & Zoghbi, H. Y. 1997 The cellular leucine rich acidic nuclear protein (LANP) interacts with ataxin-1: further insight into the pathogenesis of SCA1. Nature 389, 974-978.
50. Merry, D. E., Kobayashi, Y., Bailey, C. K., Taye, A. A. & Fischbeck, K. H. 1990 Cleavage, aggregation and toxicity of the expanded androgen receptor in spinal and bulbar muscular atrophy. Hum. Mol. Genet. 7, 693-701.
51. Miyashita, T., Okamura-Oho, Y., Mito, Y., Nagafuchi, S. & Yamada, M. 1997 Dentatorubral pallidoluysian atrophy (DRPLA) protein is cleaved by caspase-3 during apoptosis. J. Biol. Chem. 272, 29238-29242.
52. Miyashita, T., Nagao, K., Ohmi, K., Yanagisawa, H., Okamura-Oho, Y. & Yamada, M. 1998 Intracellular aggregate formation of dentatorubral pallidoluysian atrophy (DRPLA) protein with the extended polyglutamine. Biochem. Biophys. Res. Cumm. 249, 96-102.
53. Moulder, K. L., Onodera, O., Burke, J. R., Strittmatter, W. J. & Johnson Jr, E. M. 1999 Generation of neuronal intranuclear inclusions by polyglutamine-GFP: analysis of inclusion clearance and toxicity as a function of polyglutamine length. J. Neurosci. 19, 705-715.
54. Myers, R. H., Vonsattel, J. P., Stevens, T. J., Cupples, L. A., Richardson, E. P., Martin, J. B. & Bird, E. D. 1988 Clinical and neuropathologic assessment of severity in Huntington's disease. Neurology 38, 341-347.
55. Nance, M. A. 1997 Clinical aspects of CAG repeat diseases. Brain Pathol, 7, 881-900.
56. Ordway, J. M. (and 11 others) 1997 Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell 91, 753-763.
57. Paulson, H. L. & Fischbeck, K. H. 1996 Trinucleotide repeats in neurogenetic disorders. A. Rev. Neurosci. 19, 79-107.
58. Paulson, H. L., Perez, M. K., Trottier, Y, Trojanowski, J. Q., Subramony, S. H., Das, S. S., Vig, P., Mandel, J.-L., Fischbeck, K. H. & Pittman, R. N. 1997 Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 19, 333-344.
59. Perutz, M. 1991 Polar zippers: their role in human disease. Protein Sci. 3, 1629-1637.
60. Peters, M. F., Nucifora, F. C. Jr, Kushi, J., Seaman, H. J., Cooper, J. K., Herring, W. J., Dawson, V. L., Dawson, T. M. & Ross, C. A. 1999 Nuclear targeting of mutant huntingtin increases toxicity. Mol. Cell. Neurosci. (Submitted.)
61. Reddy, P. H., Williams, M., Charles, V., Garrett, L., Pike-Buchanan, L., Whetsell, W. O., Miller, C. & Tagle, D. A. 1998 Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nature Genet. 20, 198-202.
62. Ross, C., A. 1995 When more is less: pathogenesis of glutamine repeat neurodegenerative diseases. Neuron 15, 493-496.
63. Ross, C. A. 1997 Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron 19, 1147-1150.
64. Ross, C. A., Margolis, R. L., Rosenblatt, A., Ranen, N. G., Becher, M. W. & Aylward, E. A. 1997 Reviews in molecular medicine: Huntington's disease and a related disorder, dentatorubral-pallidoluysian atrophy (DRPLA). Medicine 76, 305-338.
65. Sanchez, I. & Yuan, J. 1998 Pathogenesis in triplet expansion disorders: mechanism of polyglutamine-induced apoptosis. Soc. Neurosci. Abstr. 379.10.
66. Sapp, E., Schwarz, C., Chase, K., Bide, P. G., Young, A. B., Penney, J., Vousattel, J. P., Aronin, N. & DiFiglia, M. 1997 Huntingtin localization in brains of normal and Huntington's disease patients. Ann. Neurol. 42, 604-612.
67. Saudou, F., Finkbeiner, S., Devys, D. & Greenberg, M. E. 1998 Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55-66.
68. Scherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenbach, B., Hasenbank, R., Bates, G. P., Davies, S. W., Lehrach, H. & Wanker, E. E. 1997 Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 90, 549-558.
69. Schilling, G. (and 13 others) 1999a Intranuclear inclusions and neuritic pathology in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum. Mol. Genet. (In the press.)
70. Schilling, G. (and 14 others) 1999b Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA. Nature Genet. (Submitted.)
71. Servadio, A., Koshy, B., Armstrong, D., Antalffy, B., Orr, H. T. & Zoghbi, H. Y. 1995 Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nature Genet. 10, 94-98.
72. Sharp, A. H. (and 15 others) 1995 Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 14, 1065-1074.
73. Skinner, P. J., Koshy, B. T., Cummings, C. J., Klement, I. A., Helin, K., Servadio, A., Zoghbi, H. Y. & Orr, H. T. 1997 Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 389, 971-978.
74. Stine, O. C., Pleasant, N., Franz, M. L., Abbott, M. H., Folstein, S. E. & Ross, C. A. 1993 Correlations between the onset of Huntington's disease and length of the trinucleotide repeat in IT-15. Hum. Mol. Genet. 2, 1547-1549.
75. Stott, K., Blackburn, J. M., Butler, P. J. G. & Perutz, M. 1995 Incorporation of glutamine repeats make protein cligomerize: implications for neurodegenerative diseases. Proc. Natl Acad. Sci. USA 92, 6509-6513.
76. Tait, D., Riccio, M., Sittler, A., Scherzinger, E., Santi, S., Ogiubene, A., Maraldi, N. M., Lehrach, H. & Wanker, E. E. 1998 Ataxin-3 is transported into the nucleus and associates with the nuclear matrix. Hum. Mol. Genet. 7, 991-997.
77. Trottier, Y., Cancel, G., An-Gourfinkel, I., Lutz, Y., Weber, C., Brice, A., Hirsch, E. & Mandel, J.-L. 1998 Heterogeneous intracellular localization and expression of ataxin-3. Neurobiol. Dis. 5, 335-347.
78. Vonsattel, J. P., Myers, R. H., Stevens, T. J., Ferrante, R. J., Bird, E. D. & Richardson, E. P. 1985 Neuropathological classification of Huntington's disease. J. Neuropath. Exp. Neurol. 44, 559-577.
79. Wanker, E. E., Rovira, C., Scherzinger, E., Hasenbank, R., Wälter, S., Tait, D., Colicelli, J. & Lehrach, H. 1997 HIP-1: a huntingtin interacting protein isolated by the yeast two-hybrid system. Hum. Mol. Genet. 6, 487-495.
80. Warrick, J. M., Paulson, H. L., Gray-Board, G. L., Bui, Q. T., Fischbeck, K. H., Pittman, R. N. & Bonini, N. M. 1998 Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 93,939-949.
81. Wellington, C. L. (and 20 others) 1998 Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J. Biol. Chem. 273, 9158-9167.
82. Zoghbi, H. Y. 1996 The expanding world of ataxins. Nature Genet. 14, 237-238.